"10.1371_journal.pone.0098348","plos one","2014-06-04T00:00:00Z","Diana A van Riet â€“ Nales; Erwin G A W RÃ¶mkens; Agnes Saint-Raymond; Piotr Kozarewicz; Alfred F A M Schobben; Toine C G Egberts; Carin M A Rademaker","Medicines Evaluation Board in the Netherlands (MEB), Department of Chemical Pharmaceutical Assessment, Utrecht, the Netherlands; Utrecht University, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht, the Netherlands; European Medicines Agency, Human Medicines Special Areas, London, United Kingdom; European Medicines Agency, Quality of Medicines, London, United Kingdom; University Medical Centre Utrecht, Department of Clinical Pharmacy, Utrecht, the Netherlands","Conceived and designed the experiments: DVR ER ASR PK AS TE CR. Performed the experiments: DVR ER. Analyzed the data: DVR ER PK AS TE CR. Contributed reagents/materials/analysis tools: ASR. Wrote the paper: DVR ER ASR PK AS TE CR. All authors were involved in the design of this study.","Diana van Riet is vice chair of the European Medicines Agencys (EMAs) Quality Working Party for human medicines and an EMA expert. Alfred Schobben is a member of the Medicines Evaluation Board in the Netherlands and EMA expert. Toine Egberts is also an EMA expert. Agnes Saint-Raymond and Piotr Kozarewicz are full time employees of the EMA. There are no patents, products in development or marketed products to declare. The data on which this study is based can be obtained from the authors or from the EMA upon request. This declaration does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","06","Diana A van Riet â€“ Nales","DAVRÂN",7,TRUE,7,2,6,7,TRUE,TRUE,FALSE,0,NA,FALSE
